Lifestyle and homocysteine levels
- Homocysteine Levels and Cardiovascular Disease. Sadovsky, Richard // American Family Physician;02/15/2000, Vol. 61 Issue 4, p1183
Provides information on the study `Homocysteine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence,' by J.W. Eikelboom and colleagues published in the September 7, 1999 issue of the `Annals of Internal Medicine.'
- New risk markers for predicting vascular disease--help or hindrance? Anand, Sonia // Clinical & Investigative Medicine;Aug2000, Vol. 23 Issue 4, p289
Editorial. Presents observations on risk markers for predicting cardiovascular disease (CVD). When the use of a risk marker should become routine; Association of homocysteine with CVD; Conventional CVD factors.
- Elevated tHcy Levels Contribute to Excess Risk of CVD Events. // Kidney;Jul/Aug98, Vol. 7 Issue 4, p166
Presents a summary of the article 'Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients,' by D. Shermin, P. Verhoef et al published in 'Arteriosclerosis, Thrombosis, and Vascular Biology' periodical.
- Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia. Riksen, Niels P.; Rongen, Gerard A.; Blom, Henk J.; Russel, Frans G.M.; Boers, Godfried H.J.; Smits, Paul // Cardiovascular Research;Aug2003, Vol. 59 Issue 2, p271
Hyperhomocysteinemia is an independent risk factor for cardiovascular disease. Most previous investigations focused on the role of homocysteine as direct pathogenetic factor for these adverse vascular events. However, the exact pathophysiological mechanism is still unknown. In this review we...
- Homocysteine-Mediated PPAR, DNA Methylation and Its Potential Pathogenic Mechanism in Monocytes. Jiang Yideng; Liu Zhihong; Xiong Jiantuan; Cao Jun; Li Guizhong; Shuren, Wang // DNA & Cell Biology;Mar2008, Vol. 27 Issue 3, p143
Homocysteine (Hcy) is an independent risk factor for cardiovascular disease, but the molecular mechanisms causing atherosclerosis in monocytes remain poorly characterized. The objective of the present study was to investigate the effects of Hcy on DNA methylation of PPAR, and the underlying...
- Familial cardiovascular disease: What role for homocysteine? // Patient Care;12/15/1997, Vol. 31 Issue 20, p146
States that modification of the homocysteine levels in children with familial hypercholerterolemia (FH) may lower their risk of cardiovascular disease (CVD). Findings of studies conducted; Details on some of the observations made; Treatment of findings attained in studies.
- B Smart. // Vegetarian Times;May2003, Issue 309, p13
Reports on the possibility for homocysteine to be a factor in causing cardiovascular disease as better-known cholesterol. Information on how to lower homocysteine levels; Comment of David Wald, a physician of Southampton General Hospital's Department of Cardiology.
- ALZHEIMER'S MAY BE LINKED TO NORMAL DIET BY-PRODUCT. Berriman, Mark; Fraser, Robert; French, Roger // New Vegetarian & Natural Health;Winter2002, p11
Examines the connection between high homocysteine levels and the development of Alzheimer's disease. Damage of the blood vessels and nerves; Food sources to lower homocysteine level; Efforts to identify the mechanism causing high homocysteine levels in Alzheimer's.
- Concerning Arterial Hypertension, Homocysteine and Paraoxonase-1. Rodr�guez-Esparrag�n, F.; Caballero-Hidalgo, A.; Hern�ndez-Trujillo, Y.; Mac�as-Reyes, A.; Rodr�guez-P�rez, J. C. // Current Hypertension Reviews;2007, Vol. 3 Issue 1, p51
An increased concentration of homocysteine (Hcy) is considered an independent and graded cardiovascular risk factor. Hcy can be non-specifically activated by methionyl-tRNA synthetase to Homocysteine thiolactone (HTL). HTL is hydrolyzed to Hcy by the paraoxonase/Thiolactonase (PON1) enzyme. PON1...